S. Guerra, T. Vyse, C. Graham, and D. , The genetics of lupus: a functional perspective, Arthritis Research & Therapy, vol.14, issue.3, p.211, 2012.
DOI : 10.1186/ar3844

N. Kasitanon, L. Magder, and M. Petri, Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore), pp.147-56, 2006.

M. Petri, M. Kim, K. Kalunian, J. Grossman, B. Hahn et al., Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus, New England Journal of Medicine, vol.353, issue.24, pp.2550-2558, 2005.
DOI : 10.1056/NEJMoa051135

M. Formica, J. Palmer, L. Rosenberg, and T. Mcalindon, Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study, J Rheumatol, vol.30, issue.6, pp.1222-1228, 2003.

A. Borchers, C. Keen, and M. Gershwin, Drug-Induced Lupus, Annals of the New York Academy of Sciences, vol.99, issue.1, 2007.
DOI : 10.1001/archinte.162.7.834

D. Rigante, M. Mazzoni, and S. Esposito, The cryptic interplay between systemic lupus erythematosus and infections, Autoimmunity Reviews, vol.13, issue.2, pp.96-102, 2014.
DOI : 10.1016/j.autrev.2013.09.004

L. Arnaud, J. Fagot, A. Mathian, M. Paita, A. Fagot-campagna et al., Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study, Autoimmunity Reviews, vol.13, issue.11, pp.1082-1091, 2014.
DOI : 10.1016/j.autrev.2014.08.034

M. Yurkovich, K. Vostretsova, W. Chen, and J. Aviña-zubieta, Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies, Arthritis Care & Research, vol.327, issue.4, pp.608-624
DOI : 10.1002/acr.22173

I. Bultink, Osteoporosis and fractures in systemic lupus erythematosus, Arthritis Care & Research, vol.61, issue.Suppl, pp.2-8
DOI : 10.1002/acr.20568

A. Kalla, A. Fataar, S. Jessop, and L. Bewerunge, Loss of trabecular bone mineral density in systemic lupus erythematosus, Arthritis & Rheumatism, vol.35, issue.12, pp.1726-1760, 1993.
DOI : 10.1002/art.1780361212

C. Mok, A. Mak, and K. Ma, Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus, Lupus, vol.12, issue.2, pp.106-118, 2005.
DOI : 10.1191/0961203305lu2039oa

M. Boyanov, R. Robeva, and P. Popivanov, Bone mineral density changes in women with systemic lupus erythematosus, Clinical Rheumatology, vol.22, issue.4-5, pp.4-5318, 2003.
DOI : 10.1007/s10067-003-0743-0

S. Uaratanawong, U. Deesomchoke, S. Lertmaharit, and S. Uaratanawong, Bone mineral density in premenopausal women with systemic lupus erythematosus, J Rheumatol, 2003.

R. Ramsey-goldman, J. Dunn, C. Huang, D. Dunlop, J. Rairie et al., Frequency of fractures in women with systemic lupus erythematosus: Comparison with united states population data, Arthritis & Rheumatism, vol.40, issue.5, pp.882-90, 1999.
DOI : 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C

C. Kok and P. Sambrook, Secondary osteoporosis in patients with an osteoporotic fracture, Best Practice & Research Clinical Rheumatology, vol.23, issue.6, pp.769-79, 2009.
DOI : 10.1016/j.berh.2009.09.006

R. Weinstein, Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity, Bone, vol.46, issue.3, pp.564-70, 2010.
DOI : 10.1016/j.bone.2009.06.030

E. Canalis, G. Mazziotti, A. Giustina, and J. Bilezikian, Glucocorticoid-induced osteoporosis, Current Opinion in Endocrinology & Diabetes, vol.7, issue.6, pp.1319-1347, 2007.
DOI : 10.1097/00060793-200012000-00005

T. Van-staa, H. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, Use of Oral Corticosteroids and Risk of Fractures, Journal of Bone and Mineral Research, vol.44, issue.Suppl 45, pp.993-1000, 2000.
DOI : 10.1359/jbmr.2000.15.6.993

J. Kanis, H. Johansson, A. Oden, O. Johnell, C. De-laet et al., A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk, Journal of Bone and Mineral Research, vol.359, issue.6, pp.893-902, 2004.
DOI : 10.1359/JBMR.040134

K. Briot, B. Cortet, C. Roux, L. Fardet, V. Abitbol et al., 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6
DOI : 10.1016/j.jbspin.2014.10.001

C. Wibaux, G. Baudens, and S. Fiorentino-devulder, Évolution de la prise encharge de l'ostéoporose cortisonique au sein du réseau rhumatisme inflam-matoire chronique du Nord-Pas-de-Calais entre, Rev, vol.77, 2007.

G. Schmajuk, E. Yelin, E. Chakravarty, L. Nelson, P. Panopolis et al., Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators, Arthritis Care & Research, vol.40, issue.7, 2010.
DOI : 10.1002/acr.20150

C. Lee, O. Almagor, D. Dunlop, S. Manzi, S. Spies et al., Self-reported fractures and associated factors in women with systemic lupus erythematosus, J Rheumatol, vol.34, issue.10, pp.2018-2041, 2007.

C. Yee, N. Crabtree, J. Skan, N. Amft, S. Bowman et al., Prevalence and predictors of fragility fractures in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.64, issue.1, 2005.
DOI : 10.1136/ard.2003.018127

I. Bultink, W. Lems, P. Kostense, B. Dijkmans, and A. Voskuyl, Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.7, issue.7, pp.2044-50, 2005.
DOI : 10.1002/art.21110

A. Zonana-nacach, S. Barr, L. Magder, and M. Petri, Damage in systemic lupus erythematosus and its association with corticosteroids, Arthritis & Rheumatism, vol.13, issue.8, pp.1801-1809, 2000.
DOI : 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O

K. Uramoto, C. Michet, J. Thumboo, J. Sunku, O. Fallon et al., Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992, Arthritis & Rheumatism, vol.71, issue.1, pp.46-50, 1999.
DOI : 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2

R. Cervera, M. Khamashta, J. Font, G. Sebastiani, A. Gil et al., Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period, Medicine, vol.82, issue.5, 2003.
DOI : 10.1097/01.md.0000091181.93122.55

C. Yee, L. Su, V. Toescu, R. Hickman, D. Situnayake et al., Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years, Rheumatology, vol.54, issue.5, pp.836-879
DOI : 10.1093/rheumatology/keu412

G. Thomas, J. Mancini, N. Jourde-chiche, G. Sarlon, Z. Amoura et al., Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis, Arthritis & Rheumatology, vol.64, issue.9, pp.2503-2514, 2014.
DOI : 10.1002/art.38731

M. Wiktorowicz, R. Goeree, A. Papaioannou, J. Adachi, and E. Papadimitropoulos, Economic Implications of Hip Fracture: Health Service Use, Institutional Care and Cost in Canada, Osteoporosis International, vol.12, issue.4, pp.271-279, 2014.
DOI : 10.1007/s001980170116

L. Melton, Excess Mortality Following Vertebral Fracture, Journal of the American Geriatrics Society, vol.22, issue.Supplement 3, pp.338-347, 2000.
DOI : 10.1111/j.1532-5415.2000.tb02658.x

S. Uaratanawong, U. Deesomchoke, S. Lertmaharit, and S. Uaratanawong, Bone mineral density in premenopausal women with systemic lupus erythematosus, J Rheumatol, vol.30, issue.11, pp.2365-2373, 2003.

M. Boyanov, R. Robeva, and P. Popivanov, Bone mineral density changes in women with systemic lupus erythematosus, Clinical Rheumatology, vol.22, issue.4-5, pp.4-5318, 2003.
DOI : 10.1007/s10067-003-0743-0

S. Ekblom-kullberg, H. Kautiainen, P. Alha, M. Leirisalo-repo, and H. Julkunen, Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus, Scandinavian Journal of Rheumatology, vol.46, issue.5, pp.390-393, 2013.
DOI : 10.1002/art.21110

S. Lakshminarayanan, S. Walsh, M. Mohanraj, and N. Rothfield, Factors associated with low bone mineral density in female patients with systemic lupus erythematosus, J Rheumatol, vol.28, issue.1, pp.102-110, 2001.

C. Kok and P. Sambrook, Secondary osteoporosis in patients with an osteoporotic fracture, Best Practice & Research Clinical Rheumatology, vol.23, issue.6, pp.769-79, 2009.
DOI : 10.1016/j.berh.2009.09.006

T. Van-staa, H. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, Use of Oral Corticosteroids and Risk of Fractures, Journal of Bone and Mineral Research, vol.44, issue.Suppl 45, pp.993-1000, 2000.
DOI : 10.1359/jbmr.2000.15.6.993

E. Canalis, G. Mazziotti, A. Giustina, and J. Bilezikian, Glucocorticoid-induced osteoporosis, Current Opinion in Endocrinology & Diabetes, vol.7, issue.6, pp.1319-1347, 2007.
DOI : 10.1097/00060793-200012000-00005

R. Weinstein, Glucocorticoid-Induced Osteoporosis and Osteonecrosis, Endocrinology and Metabolism Clinics of North America, vol.41, issue.3, pp.595-611, 2012.
DOI : 10.1016/j.ecl.2012.04.004

C. Wibaux, G. Baudens, and S. Fiorentino-devulder, Évolution de la prise encharge de l'ostéoporose cortisonique au sein du réseau rhumatisme inflam-matoire chronique du Nord-Pas-de-Calais entre, Rev, vol.77, p.86, 2007.

I. Bultink, W. Lems, P. Kostense, B. Dijkmans, and A. Voskuyl, Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.7, issue.7, pp.2044-50, 2005.
DOI : 10.1002/art.21110

C. Yee, N. Crabtree, J. Skan, N. Amft, S. Bowman et al., Prevalence and predictors of fragility fractures in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.64, issue.1, 2005.
DOI : 10.1136/ard.2003.018127

S. B. Green and A. Pappas, Effects of maternal bisphosphonate use on fetal and neonatal outcomes, American Journal of Health-System Pharmacy, vol.71, issue.23, pp.2029-2065, 2014.
DOI : 10.2146/ajhp140041

N. Djokanovic, C. Klieger-grossmann, and G. Koren, Does Treatment With Bisphosphonates Endanger the Human Pregnancy?, Journal of Obstetrics and Gynaecology Canada, vol.30, issue.12, pp.1146-1154, 2008.
DOI : 10.1016/S1701-2163(16)34026-9

E. Tan, A. Cohen, J. Fries, A. Masi, D. Mcshane et al., The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1278, 1982.
DOI : 10.1002/art.1780251101

C. Bombardier, D. Gladman, M. Urowitz, D. Caron, and C. Chang, Derivation of the sledai. A disease activity index for lupus patients, Arthritis & Rheumatism, vol.19, issue.6, pp.630-670, 1992.
DOI : 10.1002/art.1780350606

D. Gladman, E. Ginzler, C. Goldsmith, P. Fortin, M. Liang et al., The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus, Arthritis & Rheumatism, vol.36, issue.3, pp.363-372, 1996.
DOI : 10.1002/art.1780390303

K. Briot, B. Cortet, C. Roux, L. Fardet, V. Abitbol et al., 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6, pp.493-501, 2014.
DOI : 10.1016/j.jbspin.2014.10.001

G. Schmajuk, E. Yelin, E. Chakravarty, L. Nelson, P. Panopolis et al., Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators, Arthritis Care & Research, vol.40, issue.7, 2010.
DOI : 10.1002/acr.20150

K. Almehed, H. Forsblad-d-'elia, G. Kvist, C. Ohlsson, and H. Carlsten, Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatol Oxf Engl, pp.1185-90, 2007.

C. Gordon, Long-term complications of systemic lupus erythematosus, Rheumatology, vol.41, issue.10, pp.1095-100, 2002.
DOI : 10.1093/rheumatology/41.10.1095

P. Chugh, Management of women with systemic lupus erythematosus, Maturitas, vol.75, issue.3, pp.207-221, 2013.
DOI : 10.1016/j.maturitas.2013.03.019

L. Ledwich and K. Clarke, Screening and Treatment of Glucocorticoid-Induced Osteoporosis in Rheumatoid Arthritis Patients in an Urban Multispecialty Practice, JCR: Journal of Clinical Rheumatology, vol.15, issue.2, pp.61-65, 2009.
DOI : 10.1097/RHU.0b013e31819b65bd

D. Solomon, J. Katz, J. Jacobs, L. Tourette, A. Coblyn et al., Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice, Arthritis & Rheumatism, vol.280, issue.12, pp.3136-3178, 2002.
DOI : 10.1002/art.10613

M. Bolland, A. Grey, A. Avenell, and I. Reid, Calcium Supplements Increase Risk of Myocardial Infarction, Journal of Bone and Mineral Research, vol.77, issue.2, p.2015
DOI : 10.1002/jbmr.2311

I. Reid, S. Bristow, and M. Bolland, Calcium supplements: benefits and risks, Journal of Internal Medicine, vol.89, issue.4, 2015.
DOI : 10.1111/joim.12394

I. Reid, S. Bristow, and M. Bolland, Cardiovascular Complications of Calcium Supplements, Journal of Cellular Biochemistry, vol.66, issue.4, pp.494-501
DOI : 10.1002/jcb.25028

K. Li, R. Kaaks, J. Linseisen, and S. Rohrmann, Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg) Heart Br Card Soc, pp.920-925, 2012.

C. Solomon, M. Connelly, K. Collins, K. Okamura, and E. Seely, Provider characteristics: impact on bone density utilization at a health maintenance organization, Menopause, vol.7, issue.6, pp.391-395, 2000.
DOI : 10.1097/00042192-200011000-00004

D. Solomon, M. Brookhart, T. Gandhi, A. Karson, S. Gharib et al., Adherence with osteoporosis practice guidelines: A multilevel analysis of patient, physician, and practice setting characteristics, The American Journal of Medicine, vol.117, issue.12, pp.919-943, 2004.
DOI : 10.1016/j.amjmed.2004.06.040

E. Wall and K. Walker-bone, Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology, QJM, vol.101, issue.4, pp.317-340, 2008.
DOI : 10.1093/qjmed/hcm126

V. Borba, P. Matos, S. Da, P. Viana, A. Fernandes et al., High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients, Lupus, vol.14, issue.7, pp.529-562, 2005.
DOI : 10.1191/0961203305lu2154oa

E. Rhew, C. Lee, P. Eksarko, A. Dyer, H. Tily et al., Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus, J Rheumatol. Feb, vol.35, issue.2, pp.230-236, 2008.

I. Bultink and N. , Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom, Osteoporosis International, vol.57, issue.4, 2013.
DOI : 10.1007/s00198-013-2587-z

T. Marshall, P. Westerby, J. Chen, M. Fairfield, J. Harding et al., The Sandwell Project: A controlled evaluation of a programme of targeted screening for prevention of cardiovascular disease in primary care, BMC Public Health, vol.16, issue.1, p.73, 2008.
DOI : 10.1136/qshc.2006.019778

M. Mohammed, C. Sayed, and T. Marshall, Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment, Medical Decision Making, vol.32, issue.3, pp.498-506, 2012.
DOI : 10.1177/0272989X12437246

C. Winston, A. Mims, and K. Leatherwood, Increasing pneumococcal vaccination in managed care through telephone outreach, Am J Manag Care, vol.13, issue.10, pp.581-589, 2007.

E. Clark, V. Gould, L. Morrison, A. Ades, P. Dieppe et al., Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for skeletal health in Bristol and Avon (COSHIBA), Journal of Bone and Mineral Research, vol.23, issue.Suppl 1, pp.664-71, 2012.
DOI : 10.1002/jbmr.1478

M. Dougados, M. Soubrier, E. Perrodeau, L. Gossec, F. Fayet et al., Impact of a nurse-led programme on comorbidity management and impact of a patient selfassessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) Ann Rheum Dis, pp.2013-204733, 2014.

C. Hua, J. Morel, E. Ardouin, R. E. Foret, J. Mathieu et al., Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients, Rheumatology, vol.54, issue.4, pp.748-50, 2015.
DOI : 10.1093/rheumatology/keu531